Apoptosis induction in colon cancer cells (SW480) by BiFe
Humans
Chlorella vulgaris
/ metabolism
bcl-2-Associated X Protein
/ metabolism
Spectroscopy, Fourier Transform Infrared
Apoptosis
Colonic Neoplasms
/ drug therapy
Antineoplastic Agents
/ pharmacology
Nanocomposites
/ chemistry
Metal Nanoparticles
/ chemistry
Caspase 8
/ metabolism
Proto-Oncogene Proteins c-bcl-2
/ genetics
Apoptosis
Bismuth
Colon cancer
Nanocomposite
SW480
Journal
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
ISSN: 1878-3252
Titre abrégé: J Trace Elem Med Biol
Pays: Germany
ID NLM: 9508274
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
received:
18
08
2023
revised:
25
10
2023
accepted:
13
12
2023
medline:
18
3
2024
pubmed:
5
1
2024
entrez:
4
1
2024
Statut:
ppublish
Résumé
The use of nanomaterials in cancer diagnosis and treatment has received considerable interest. Preparation of nanoscale complex molecules could be considered to improve the efficacy and minimize toxicity of the product. This work aimed to biosynthesize BiFe The physicochemical properties of the bioengineered BiFe Physicochemical assays indicated the nanoscale synthesis (10-70 nm) and functionalization of BiFe The considerable anticancer potential of the synthesized BiFe
Sections du résumé
BACKGROUND
BACKGROUND
The use of nanomaterials in cancer diagnosis and treatment has received considerable interest. Preparation of nanoscale complex molecules could be considered to improve the efficacy and minimize toxicity of the product. This work aimed to biosynthesize BiFe
METHODS
METHODS
The physicochemical properties of the bioengineered BiFe
RESULTS
RESULTS
Physicochemical assays indicated the nanoscale synthesis (10-70 nm) and functionalization of BiFe
CONCLUSION
CONCLUSIONS
The considerable anticancer potential of the synthesized BiFe
Identifiants
pubmed: 38176316
pii: S0946-672X(23)00245-6
doi: 10.1016/j.jtemb.2023.127369
pii:
doi:
Substances chimiques
bcl-2-Associated X Protein
0
Antineoplastic Agents
0
CASP8 protein, human
EC 3.4.22.-
Caspase 8
EC 3.4.22.-
BCL2 protein, human
0
Proto-Oncogene Proteins c-bcl-2
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
127369Informations de copyright
Copyright © 2024 Elsevier GmbH. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The researchers stated that there was no contrasting interest.